AKT1 and concussion: Importantly, by identifying and validating the MSC-Exos/PI3K/AKT/mTOR/GPX4 axis as a novel regulatory mechanism, this study provides new insights into the molecular basis of mTBI-induced cognitive dysfunction and offers a promising therapeutic strategy for its intervention.